FDA/DIA Co-sponsored Conference on The Orphan Drug Act (ODA) at 25 Years: Retrospective and Future V
Venue: Capitol Hilton
Location: Washington, Washington DC, United States
Event Date/Time: Mar 24, 2008 |
Description
Current updates on the processes, procedures, and resources to enable the successful movement of products for rare diseases from research to approval will be discussed. This will include information on Orphan Drug Designation applications,
Humanitarian Use Device designation applications, and Orphan Products Grant applications as well as other regulatory components.